“…In the last years, different approaches have emerged to correct a point mutation at the DNA level without provoking doublestrand breaks (DSB): chimeric RNA-DNA oligonucleotides, which were first designed by Kmiec's group (Yoon et al, 1996); single-stranded oligonucleotides, studied for the first time in 1988 (Moerschell et al, 1988); bifunctional triplehelix-forming oligonucleotides, formed by two domains, a triplex forming oligonucleotide (TFO) domain and a repair domain (Chan et al, 1999;Culver et al, 1999); and several approaches of peptide nucleic acids (PNA) (Nielsen et al, 1991;Egholm et al, 1993), bis-PNA (Rogers et al, 2002;Chin et al, 2008), tc-PNA (Bentin et al, 2003;Kaihatsu et al, 2003), pc-PNA (Lohse et al, 1999) (Demidov et al, 2002;Lonkar et al, 2009), and more recently PNA-single-stranded oligodeoxynucleotides (ssODNs) (Kayali et al, 2010;NikAhd and Bertoni, 2014).…”